Pediatric patients with DTC who are younger than 11 years at diagnosis have more aggressive disease features and a lower early remission rate than older patients, although their long-term outcome is satisfactory.
Does Mutational Analysis Influence the Management of Differentiated Thyroid Cancers?
It is evident that BRAF does predict recurrence and unfavorable characteristics in differentiated thyroid cancers (DTC).